201. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors
- Author
-
Mathias Zink, Markus Schwaninger, Christiane Brandwein, Peter Gass, Carles Sanchis-Segura, Ioana Inta, Alexandre Urani, and Sabine Chourbaji
- Subjects
medicine.medical_specialty ,Learned helplessness ,Anxiety ,Hippocampus ,lcsh:RC321-571 ,Pathogenesis ,Mice ,Downregulation and upregulation ,Helplessness, Learned ,Internal medicine ,medicine ,Hippocampus (mythology) ,Animals ,Genetic Predisposition to Disease ,Animal model ,Interleukin 6 ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Brain Chemistry ,Mice, Knockout ,Depressive Disorder ,IL-6 ,biology ,Behavior, Animal ,Interleukin-6 ,Depression ,Anxiety Disorders ,Tail suspension test ,Pathophysiology ,Mice, Inbred C57BL ,Disease Models, Animal ,Endocrinology ,Neurology ,Knockout mouse ,biology.protein ,Cytokines ,Psychology ,Neuroscience ,Stress, Psychological ,Signal Transduction ,Knockout mice - Abstract
Cytokine-dependent mechanisms in the CNS have been implicated in the pathogenesis of depression. Interleukin-6 is upregulated in depressed patients and dowregulated by antidepressants. It is, however, unknown whether IL-6 is involved in the pathogenesis of depression. We subjected IL-6-deficient mice (IL-6(-/-)) to depression-related tests (learned helplessness, forced swimming, tail suspension, sucrose preference). We also investigated IL-6 in the hippocampus of stressed wild-type mice. IL-6(-/-) mice showed reduced despair in the forced swim, and tail suspension test, and enhanced hedonic behavior. Moreover, IL-6(-/-) mice exhibited resistance to helplessness. This resistance may be caused by the lack of IL-6, because stress increased IL-6 expression in wild-type hippocampi. This suggests that IL-6 is a component in molecular mechanisms in the pathogenesis of depression. IL-6(-/-) mice represent tools to study IL-6-dependent signaling pathways in the pathophysiology of depression in vivo. Moreover, these mice may support the screening of compounds for depression by altering cytokine-mediated signaling.
- Published
- 2006